DEFA14A: OS Therapies Inc. Adjourns Special Meeting Due to Lack of Quorum, Reconvenes April 9

OS Therapies Inc. adjourned its Special Meeting of Stockholders on March 31, 2025, due to the absence of a quorum and will reconvene on April 9, 2025.

Summary

• OS Therapies Incorporated held a Special Meeting of Stockholders on March 31, 2025.
• The meeting was adjourned due to the lack of a quorum.
• The Special Meeting will reconvene on April 9, 2025, at the offices of Olshan Frome Wolosky LLP.
• The purpose of the meeting is to vote on the proposals described in the proxy statement filed with the SEC on February 28, 2025.
• The record date for determining stockholders entitled to vote remains February 12, 2025.
• Stockholders who have already submitted their proxy do not need to take any action if they do not want to change their vote.
• The Company will continue to solicit votes from its stockholders during the adjournment period.
• The deadline for voting is April 8, 2025, at 11:59 p.m. Eastern time, but votes received before the reconvened meeting on April 9, 2025, will be accepted.
• The Company encourages all stockholders of record as of February 12, 2025, who have not yet voted, to do so.

Sentiment

Score: 5

Explanation: The announcement is neutral, detailing a procedural matter regarding a shareholder meeting. It doesn't contain overtly positive or negative information.

Positives

• The company is actively soliciting votes to ensure stockholder participation.
• Stockholders who have already voted do not need to take further action unless they wish to change their vote.

Negatives

• The adjournment of the Special Meeting indicates a potential lack of stockholder engagement or difficulty in achieving quorum.

Risks

• Failure to achieve a quorum at the reconvened meeting could further delay the voting process.
• Low stockholder participation could impact the outcome of the vote on the proposals.

Future Outlook

The company will continue to solicit votes and proceed with the Special Meeting on April 9, 2025.

Management Comments

• The Company encourages all stockholders of record as of the close of business on February 12, 2025, who have not yet voted, to do so by April 8, 2025 at 11:59 p.m., Eastern time.

Industry Context

This announcement is a standard procedural update related to corporate governance and shareholder meetings, common among publicly traded companies.

Stakeholder Impact

• Shareholders are impacted by the delay and need to be informed about the reconvened meeting and voting procedures.
• The outcome of the vote at the Special Meeting could impact the company's future direction and strategy.

Next Steps

• The Company will continue to solicit votes from stockholders.
• The Special Meeting will reconvene on April 9, 2025.

Key Dates

Keywords

Special Meeting, Stockholders, Adjournment, Proxy Statement, Quorum, Vote, OS Therapies